Skip to content

Insider · CIK 0001636642

Matthew Maxwell Donley

cooofficer

Files at AUPH (Aurinia Pharmaceuticals Inc.). First filing Mar 4, 2025, latest Mar 4, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $994k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

AUPH: Aurinia Pharmaceuticals Inc.

AUPHOct 9, 2026 · close 16.65

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
65Notable
AUPHsell 5
Aurinia Pharmaceuticals Inc.
$994k
124,893 shares
-16%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Feb 28, 2025AUPH
Aurinia Pharmaceuticals Inc.
AGrant or award
Common Stock
+82,781$0.00$0669,791Mar 4, 2025
Mar 3, 2025AUPH
Aurinia Pharmaceuticals Inc.
AGrant or award
Common Stock
+135,567$0.00$0805,358Mar 4, 2025
Mar 3, 2025AUPH
Aurinia Pharmaceuticals Inc.
SOpen-market sale
Common Stock
-65,902$8.00$527k739,456Mar 4, 2025
Mar 4, 2025AUPH
Aurinia Pharmaceuticals Inc.
SOpen-market sale
Common Stock
-58,991$7.92$467k680,465Mar 4, 2025
Feb 28, 2025AUPH
Aurinia Pharmaceuticals Inc.
AGrant or award
Employee Stock Option (right to buy)derivative
+126,416$0.00$0126,416Mar 4, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Matthew Maxwell Donley: insider trades and track record | InsiderTell